Related Experiment Video

Updated: Jun 29, 2025

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on: April 15, 2017

17.9K

Does oseltamivir prevent hospitalisation in people with influenza?

    Drug and Therapeutics Bulletin
    |March 25, 2024
    PubMed

    Abstract:

    Overview of: Hanula R, Bortolussi-Courval É, Mendel A, et al. Evaluation of oseltamivir used to prevent hospitalization in outpatients with influenza: a systematic review and meta-analysis. JAMA Internal Medicine 2024;184:18-27.

    Keywords:
    Drug-Related Side Effects and Adverse ReactionsHealth Care Quality, Access, and Evaluation

    More Related Videos

    Optimization of a Quantitative Micro-neutralization Assay
    10:09

    Optimization of a Quantitative Micro-neutralization Assay

    Published on: December 14, 2016

    21.2K
    An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
    06:34

    An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

    Published on: December 1, 2017

    36.0K

    Related Experiment Videos

    Last Updated: Jun 29, 2025

    Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
    09:31

    Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

    Published on: April 15, 2017

    17.9K
    Optimization of a Quantitative Micro-neutralization Assay
    10:09

    Optimization of a Quantitative Micro-neutralization Assay

    Published on: December 14, 2016

    21.2K
    An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
    06:34

    An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

    Published on: December 1, 2017

    36.0K

    Related Concept Videos

    Vaccinations01:51

    Vaccinations

    44.5K
    Overview
    44.5K

    Articles linked to this work by shared authors, journal, and citation graph.

    Management of urogenital gonococcal infection.

    Drug and therapeutics bulletin·2026

    Discontinuation of levothyroxine in older adults.

    Drug and therapeutics bulletin·2026

    Pharmacological treatment of polyendocrine metabolic ovarian syndrome in adults.

    Drug and therapeutics bulletin·2026

    Lipid-lowering for people with chronic kidney disease: a narrative review.

    Drug and therapeutics bulletin·2026

    Update on spasticity: part-2 - physical, pharmacological and surgical management.

    Drug and therapeutics bulletin·2026

    Optimising treatment options in scabies.

    Drug and therapeutics bulletin·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us